AXSAIM

Accsys Technologies

FTSE AIM 100

Looking for the Accsys Technologies share chat? This is where verified investors discuss Accsys Technologies.

To see the Accsys Technologies board, create your account.

Most investors never get a thoughtful conversation about the UK shares they hold. Here you can.

We verify every member. A nickname is fine. Everyone here is a real person who owns or is thinking about the same companies as you, and has come to compare notes and ideas.

Joining is free.

Create your account Log in

What joining involves

Your email and a one-time code.
Pick your nickname.
A 30-second identity check with a photo ID, which Veriff runs for us.

Then the Accsys Technologies board opens. We never see or hold your documents, only the result. Your identity is held privately and never shown on the board.

Free for all members

The RNS Digest, in your inbox.

Every morning your companies file an RNS, you receive one email with the substantive announcements summarised in plain English.

Accsys Technologies AXS21 Sept 2026

Trading Update

Accsys reported group revenue of €56.9m for the five months to 31 August 2026, down 6% from €60.4m in the prior-year period, with aggregated revenue (including 60% of the JV) at €67.5m versus €71.6m (-6%). Group sales volumes fell 11% to 22,186m³ while JV volumes rose 3% to 6,767m³, giving total volumes of 28,953m³ versus 31,376m³ (-8%). The company cited macroeconomic headwinds, the Middle East conflict and significant distributor destocking, particularly in North America, though it says destocking has ended and trading improved in September; full-year North America growth is expected at single-digit levels. For FY27, the Board expects full year underlying EBITDA (excluding the JV) to be broadly in line with market expectations (stated as €24.5m consensus) on lower revenues, while adjusted EBITDA is expected to be ahead of the prior year, in a range of €21m to €23m, against a stated consensus of €28.8m. Interim results are scheduled for 24 November 2026.

Summarised by The Shareholders Board from the RNS.

Nothing on this page is investment advice or a recommendation to buy or sell any security. It is a place to discuss the companies you own with other verified investors.